Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema
Clin Exp Allergy. 2022 Mar 12. doi: 10.1111/cea.14122. Online ahead of print. ABSTRACT BACKGROUND: Hereditary angioedema (HAE) is a rare genetic disease that leads to